Thymic damage occurs secondary to allogeneic T lymphocytotoxicity during aGvHD, corticosteroid-mediated damage, and other non-selective T lymphocyte-suppressive agents used in the treatment of aGvHD, causing impaired thymopoiesis (
A), with reduced thymic export and a distorted T cell receptor (TCR) repertoire with potentially autoreactive thymocytes escaping negative selection (
B). ECP, by promoting immune tolerance and enabling reduction and cessation of conventional immunosuppression, may allow thymic recovery, resumption of normal thymopoiesis, and complete and long-lasting immunoreconstitution post-haematopoietic stem cell transplantation (
C). Abbreviations: Treg, regulatory T lymphocyte; DP, double positive.